PRELUDE THERAPEUTICS INC
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-21.9M | $-22.8M | $952.0K | $6.8M |
| Jun 2022 | $-18.5M | $-19.2M | $758.0K | $6.0M |
| Sep 2022 | $-20.4M | $-21.4M | $916.0K | $6.4M |
| Dec 2022 | $-22.9M | $-23.3M | $393.0K | $5.8M |
| Mar 2023 | $-30.1M | $-30.9M | $810.0K | $6.3M |
| Jun 2023 | $-27.7M | $-28.7M | $983.0K | $6.7M |
| Sep 2023 | $-25.7M | $-26.3M | $591.0K | $6.7M |
| Dec 2023 | $-23.6M | $-24.7M | $1.1M | $5.9M |
| Mar 2024 | $-31.8M | $-32.1M | $289.0K | $5.5M |
| Jun 2024 | $-23.1M | $-23.4M | $359.0K | $6.1M |
| Sep 2024 | $-27.3M | $-27.4M | $63.0K | $5.9M |
| Dec 2024 | $-20.7M | $-20.8M | $53.0K | $3.8M |
| Mar 2025 | $-34.2M | $-34.3M | $47.0K | $3.8M |
| Jun 2025 | $-26.1M | $-26.1M | $20.0K | $3.8M |
| Sep 2025 | $-19.1M | $-19.1M | $0 | $2.4M |
| Dec 2025 | $23.1M | $23.1M | $0 | $1.8M |
| Mar 2026 | $-21.7M | $-21.7M | $0 | $2.0M |
| Jun 2026 | $-15.6M | $-15.6M | $0 | $2.0M |